Search

Search Constraints

You searched for: Author/Creator Keymeulen, Bart

Search Results

1. Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression. Issue 9 (September 2017)

3. Cell Mass Increase Associated with Formation of Glucose-Controlling β-Cell Mass in Device-Encapsulated Implants of hiPS-Derived Pancreatic Endoderm. (4th August 2019)

4. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial. Issue 10291 (12th June 2021)

5. Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop. Issue 9 (September 2018)

6. Defining outcomes for β‐cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop. (25th March 2018)

7. Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial. Issue 2 (February 2023)

8. Formation of amyloid in encapsulated human pancreatic and human stem cell‐generated beta cell implants. Issue 6 (6th December 2020)

9. Function and composition of pancreatic islet cell implants in omentum of type 1 diabetes patients. Issue 3 (16th November 2021)

10. Heterogeneity of Human Pancreatic Islet Isolation Around Europe: Results of a Survey Study. Issue 1 (January 2020)